These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9784135)

  • 1. An MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbits.
    Wetterau JR; Gregg RE; Harrity TW; Arbeeny C; Cap M; Connolly F; Chu CH; George RJ; Gordon DA; Jamil H; Jolibois KG; Kunselman LK; Lan SJ; Maccagnan TJ; Ricci B; Yan M; Young D; Chen Y; Fryszman OM; Logan JV; Musial CL; Poss MA; Robl JA; Simpkins LM; Slusarchyk WA; Sulsky R; Taunk P; Magnin DR; Tino JA; Lawrence RM; Dickson JK; Biller SA
    Science; 1998 Oct; 282(5389):751-4. PubMed ID: 9784135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MTP inhibitor decreases plasma cholesterol levels in LDL receptor-deficient WHHL rabbits by lowering the VLDL secretion.
    Shiomi M; Ito T
    Eur J Pharmacol; 2001 Nov; 431(1):127-31. PubMed ID: 11716851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-lowering effects of TAK-475, a squalene synthase inhibitor, in animal models of familial hypercholesterolemia.
    Amano Y; Nishimoto T; Tozawa Ri; Ishikawa E; Imura Y; Sugiyama Y
    Eur J Pharmacol; 2003 Apr; 466(1-2):155-61. PubMed ID: 12679152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An inhibitor of the microsomal triglyceride transfer protein inhibits apoB secretion from HepG2 cells.
    Jamil H; Gordon DA; Eustice DC; Brooks CM; Dickson JK; Chen Y; Ricci B; Chu CH; Harrity TW; Ciosek CP; Biller SA; Gregg RE; Wetterau JR
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11991-5. PubMed ID: 8876250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress towards understanding the role of microsomal triglyceride transfer protein in apolipoprotein-B lipoprotein assembly.
    Gordon DA; Jamil H
    Biochim Biophys Acta; 2000 Jun; 1486(1):72-83. PubMed ID: 10856714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel series of highly potent benzimidazole-based microsomal triglyceride transfer protein inhibitors.
    Robl JA; Sulsky R; Sun CQ; Simpkins LM; Wang T; Dickson JK; Chen Y; Magnin DR; Taunk P; Slusarchyk WA; Biller SA; Lan SJ; Connolly F; Kunselman LK; Sabrah T; Jamil H; Gordon D; Harrity TW; Wetterau JR
    J Med Chem; 2001 Mar; 44(6):851-6. PubMed ID: 11300866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New lipid modulating drugs: the role of microsomal transport protein inhibitors.
    Rizzo M; Wierzbicki AS
    Curr Pharm Des; 2011; 17(9):943-9. PubMed ID: 21418029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential impact of hepatic deficiency and total body inhibition of MTP on cholesterol metabolism and RCT in mice.
    Dikkers A; Annema W; de Boer JF; Iqbal J; Hussain MM; Tietge UJ
    J Lipid Res; 2014 May; 55(5):816-25. PubMed ID: 24511105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase in hepatic low-density lipoprotein receptor activity during pregnancy in Watanabe heritable hyperlipidemic rabbits; an animal model for familial hypercholesterolemia.
    Shiomi M; Ito T; Watanabe Y
    Biochim Biophys Acta; 1987 Jan; 917(1):92-100. PubMed ID: 3790616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term clinical results of microsomal triglyceride transfer protein inhibitor use in a patient with homozygous familial hypercholesterolemia.
    Raper A; Kolansky DM; Sachais BS; Meagher EA; Baer AL; Cuchel M
    J Clin Lipidol; 2015; 9(1):107-12. PubMed ID: 25670368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced aortic atherosclerosis in transgenic Watanabe heritable hyperlipidemic rabbits expressing lipoprotein lipase.
    Koike T; Liang J; Wang X; Ichikawa T; Shiomi M; Sun H; Watanabe T; Liu G; Fan J
    Cardiovasc Res; 2005 Feb; 65(2):524-34. PubMed ID: 15639492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CP-346086: an MTP inhibitor that lowers plasma cholesterol and triglycerides in experimental animals and in humans.
    Chandler CE; Wilder DE; Pettini JL; Savoy YE; Petras SF; Chang G; Vincent J; Harwood HJ
    J Lipid Res; 2003 Oct; 44(10):1887-901. PubMed ID: 12837854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia.
    Cuchel M; Bloedon LT; Szapary PO; Kolansky DM; Wolfe ML; Sarkis A; Millar JS; Ikewaki K; Siegelman ES; Gregg RE; Rader DJ
    N Engl J Med; 2007 Jan; 356(2):148-56. PubMed ID: 17215532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of the lipoprotein structure in the St. Thomas' Mixed Hyperlipidaemic (SMHL) rabbit.
    de Roos B; Caslake MJ; Milliner K; Benson GM; Suckling KE; Packard CJ
    Atherosclerosis; 2005 Jul; 181(1):63-8. PubMed ID: 15939055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of low density lipoprotein receptor deficiency on the metabolism of apolipoprotein B-100 in blood plasma. Kinetic studies in normal and Watanabe heritable hyperlipidemic rabbits.
    Yamada N; Shames DM; Havel RJ
    J Clin Invest; 1987 Aug; 80(2):507-15. PubMed ID: 3611356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte apoB-containing lipoprotein secretion is decreased by the grapefruit flavonoid, naringenin, via inhibition of MTP-mediated microsomal triglyceride accumulation.
    Borradaile NM; de Dreu LE; Barrett PH; Behrsin CD; Huff MW
    Biochemistry; 2003 Feb; 42(5):1283-91. PubMed ID: 12564931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of oral l-carnitine on lipoprotein composition in the Watanabe Heritable Hyperlipidemic Rabbit (Oryctolagus cuniculus).
    Raymond TL; Reynolds SA; Swanson JA; Patnode CA; Bell FP
    Comp Biochem Physiol A Comp Physiol; 1987; 88(3):503-6. PubMed ID: 2892624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretion of lipoproteins from the liver of normal and Watanabe heritable hyperlipidemic rabbits.
    Hornick CA; Kita T; Hamilton RL; Kane JP; Havel RJ
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6096-100. PubMed ID: 6577469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A small-molecule inhibitor of enterocytic microsomal triglyceride transfer protein, SLx-4090: biochemical, pharmacodynamic, pharmacokinetic, and safety profile.
    Kim E; Campbell S; Schueller O; Wong E; Cole B; Kuo J; Ellis J; Ferkany J; Sweetnam P
    J Pharmacol Exp Ther; 2011 Jun; 337(3):775-85. PubMed ID: 21406547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of bezafibrate on lipoprotein lipids and apolipoproteins B and A1 in patients with primary hypercholesterolemia].
    Branchi A; Sommariva D; Tirrito M; Bonfiglioli D; Pini C; Scandiani L; Orlandi S; Fasoli A
    Clin Ter; 1987 Jul; 122(1):17-23. PubMed ID: 2973892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.